| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 2.31e-08 | 16 | 114 | 5 | GO:0042043 | |
| GeneOntologyMolecularFunction | disaccharide binding | 6.24e-06 | 7 | 114 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.48e-05 | 9 | 114 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.92e-04 | 20 | 114 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.93e-04 | 93 | 114 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate binding | 6.66e-04 | 7 | 114 | 2 | GO:1902387 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.16e-09 | 10 | 114 | 5 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.12e-09 | 11 | 114 | 5 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 5.87e-09 | 13 | 114 | 5 | GO:0097090 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.96e-08 | 16 | 114 | 5 | GO:0007158 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.55e-07 | 4 | 114 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 4.93e-06 | 21 | 114 | 4 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 5.78e-06 | 81 | 114 | 6 | GO:0043030 | |
| GeneOntologyBiologicalProcess | receptor clustering | 6.67e-06 | 83 | 114 | 6 | GO:0043113 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 9.02e-06 | 8 | 114 | 3 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 9.02e-06 | 8 | 114 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 9.02e-06 | 8 | 114 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 1.20e-05 | 26 | 114 | 4 | GO:1900424 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.29e-05 | 93 | 114 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.35e-05 | 9 | 114 | 3 | GO:0072553 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 1.44e-05 | 56 | 114 | 5 | GO:0001941 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 2.02e-05 | 60 | 114 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | membrane assembly | 2.78e-05 | 64 | 114 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 2.99e-05 | 65 | 114 | 5 | GO:0098815 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 3.49e-05 | 12 | 114 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 5.26e-05 | 73 | 114 | 5 | GO:0044091 | |
| GeneOntologyBiologicalProcess | presynapse organization | 5.26e-05 | 73 | 114 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | social behavior | 5.61e-05 | 74 | 114 | 5 | GO:0035176 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 5.65e-05 | 38 | 114 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 5.73e-05 | 14 | 114 | 3 | GO:0002087 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 6.38e-05 | 76 | 114 | 5 | GO:0051703 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 7.13e-05 | 15 | 114 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 7.13e-05 | 15 | 114 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 8.42e-05 | 42 | 114 | 4 | GO:0043032 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 9.05e-05 | 3 | 114 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 9.25e-05 | 43 | 114 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | regulation of respiratory system process | 1.06e-04 | 17 | 114 | 3 | GO:0044065 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.06e-04 | 17 | 114 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.26e-04 | 18 | 114 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.28e-04 | 140 | 114 | 6 | GO:0042116 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.49e-04 | 19 | 114 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.49e-04 | 19 | 114 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.75e-04 | 20 | 114 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.80e-04 | 4 | 114 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.93e-04 | 96 | 114 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 2.35e-04 | 22 | 114 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 2.57e-04 | 102 | 114 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 2.60e-04 | 56 | 114 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 3.06e-04 | 24 | 114 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 3.19e-04 | 59 | 114 | 4 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 3.46e-04 | 25 | 114 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 3.62e-04 | 61 | 114 | 4 | GO:0032814 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 3.80e-04 | 111 | 114 | 5 | GO:0036465 | |
| GeneOntologyBiologicalProcess | behavior | NLGN4Y ANKRD26 LMO3 NLGN1 NR3C1 NPHP4 ADCY8 NLGN3 NLGN4X NETO1 SCN1A NLGN2 GNAO1 PCM1 | 4.02e-04 | 891 | 114 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 4.10e-04 | 63 | 114 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 4.28e-04 | 175 | 114 | 6 | GO:0031644 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 4.29e-04 | 114 | 114 | 5 | GO:0033077 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange | 4.37e-04 | 27 | 114 | 3 | GO:0043576 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 4.37e-04 | 27 | 114 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | positive regulation of glucocorticoid receptor signaling pathway | 4.48e-04 | 6 | 114 | 2 | GO:2000324 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 4.87e-04 | 28 | 114 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 5.99e-04 | 30 | 114 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 6.13e-04 | 70 | 114 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | courtship behavior | 6.24e-04 | 7 | 114 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.60e-04 | 31 | 114 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 6.60e-04 | 31 | 114 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 7.26e-04 | 32 | 114 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 7.81e-04 | 130 | 114 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 7.95e-04 | 33 | 114 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | DOCK2 LGALS9C LGALS9B DOCK10 POU2F2 ZBTB1 STAT6 LGALS9 SMARCA4 SPINK5 | 7.96e-04 | 537 | 114 | 10 | GO:0030098 |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 8.08e-04 | 131 | 114 | 5 | GO:0010469 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine morphogenesis | 8.30e-04 | 8 | 114 | 2 | GO:0061002 | |
| GeneOntologyBiologicalProcess | brainstem development | 8.30e-04 | 8 | 114 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | DOCK2 LGALS9C LGALS9B DOCK10 POU2F2 NR3C1 ZBTB1 STAT6 LGALS9 SMARCA4 SPINK5 | 8.41e-04 | 640 | 114 | 11 | GO:1903131 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.11e-03 | 37 | 114 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.12e-03 | 141 | 114 | 5 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 1.20e-03 | 38 | 114 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.23e-03 | 144 | 114 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.29e-03 | 382 | 114 | 8 | GO:0030217 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 1.32e-03 | 10 | 114 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.35e-03 | 147 | 114 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.40e-03 | 40 | 114 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.40e-03 | 40 | 114 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.50e-03 | 41 | 114 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.50e-03 | 41 | 114 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | localization within membrane | DOCK2 LGALS9C LGALS9B ABCA12 VPS39 NLGN1 LGALS9 WDR19 NETO1 ZDHHC6 VPS35L NLGN2 | 1.54e-03 | 798 | 114 | 12 | GO:0051668 |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.57e-03 | 90 | 114 | 4 | GO:0098586 | |
| GeneOntologyBiologicalProcess | hexose mediated signaling | 1.61e-03 | 11 | 114 | 2 | GO:0009757 | |
| GeneOntologyBiologicalProcess | glucose mediated signaling pathway | 1.61e-03 | 11 | 114 | 2 | GO:0010255 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 1.61e-03 | 11 | 114 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | sugar mediated signaling pathway | 1.61e-03 | 11 | 114 | 2 | GO:0010182 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.61e-03 | 42 | 114 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.62e-03 | 226 | 114 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | membrane organization | DOCK2 ABCA12 VPS39 NLGN4Y MYO18A NLGN1 PLEKHA8P1 NLGN3 NLGN4X SEC24C PLA2G4A NLGN2 KLHL12 | 1.62e-03 | 914 | 114 | 13 | GO:0061024 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 1.63e-03 | 91 | 114 | 4 | GO:0060998 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 1.73e-03 | 43 | 114 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 1.73e-03 | 43 | 114 | 3 | GO:0051968 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 8.39e-10 | 4 | 114 | 4 | GO:0098983 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.27e-07 | 107 | 114 | 8 | GO:0060076 | |
| GeneOntologyCellularComponent | symmetric synapse | 5.78e-07 | 13 | 114 | 4 | GO:0032280 | |
| GeneOntologyCellularComponent | inhibitory synapse | 6.70e-07 | 31 | 114 | 5 | GO:0060077 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 8.19e-06 | 24 | 114 | 4 | GO:0098985 | |
| GeneOntologyCellularComponent | microtubule organizing center | HMBOX1 KIF23 OFD1 MYO18A ANKRD26 EVC NR3C1 NPHP4 KIAA1217 TTC39A KLHL12 AGBL2 PCM1 DEUP1 SMTNL2 | 1.41e-04 | 919 | 114 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | glycinergic synapse | 1.68e-04 | 20 | 114 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | epidermal lamellar body | 1.76e-04 | 4 | 114 | 2 | GO:0097209 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.82e-04 | 164 | 114 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 8.27e-04 | 201 | 114 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | chromatin | HMBOX1 BRPF3 ENC1 ZBTB8B KDM3B POU2F1 POU2F2 SIN3A NR6A1 NR3C1 TFCP2 HNRNPL STAT6 HOXC6 NACC2 SMARCA4 RORB BICRAL | 1.07e-03 | 1480 | 114 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 1.25e-03 | 39 | 114 | 3 | GO:0031463 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.29e-03 | 10 | 114 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.75e-03 | 503 | 114 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.28e-03 | 523 | 114 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | dendrite | NLGN4Y DOCK10 MPDZ NLGN1 NR3C1 SCGN ADCY8 NLGN3 NLGN4X SACS NLGN2 GNAO1 | 2.52e-03 | 858 | 114 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | centriole | 2.54e-03 | 172 | 114 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | dendritic tree | NLGN4Y DOCK10 MPDZ NLGN1 NR3C1 SCGN ADCY8 NLGN3 NLGN4X SACS NLGN2 GNAO1 | 2.57e-03 | 860 | 114 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | GBAF complex | 2.57e-03 | 14 | 114 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | membrane coat | 2.72e-03 | 106 | 114 | 4 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 2.72e-03 | 106 | 114 | 4 | GO:0048475 | |
| GeneOntologyCellularComponent | somatodendritic compartment | NLGN4Y ENC1 DOCK10 MPDZ NLGN1 NR3C1 SCGN PDE10A ADCY8 NLGN3 NLGN4X SACS SCN1A NLGN2 GNAO1 | 2.76e-03 | 1228 | 114 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | COPII vesicle coat | 3.37e-03 | 16 | 114 | 2 | GO:0030127 | |
| MousePheno | abnormal social investigation | 1.79e-05 | 171 | 93 | 8 | MP:0001360 | |
| Domain | Nlgn | 7.42e-12 | 5 | 113 | 5 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 9.18e-09 | 13 | 113 | 5 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.42e-08 | 14 | 113 | 5 | PS00941 | |
| Domain | COesterase | 1.42e-08 | 14 | 113 | 5 | PF00135 | |
| Domain | CarbesteraseB | 1.42e-08 | 14 | 113 | 5 | IPR002018 | |
| Domain | NLGN4 | 3.63e-05 | 2 | 113 | 2 | IPR030025 | |
| Domain | - | 8.55e-05 | 119 | 113 | 6 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 8.55e-05 | 119 | 113 | 6 | IPR029058 | |
| Domain | Galectin_CRD | 9.31e-05 | 15 | 113 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 9.31e-05 | 15 | 113 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 9.31e-05 | 15 | 113 | 3 | SM00908 | |
| Domain | GALECTIN | 9.31e-05 | 15 | 113 | 3 | PS51304 | |
| Domain | GLECT | 9.31e-05 | 15 | 113 | 3 | SM00276 | |
| Domain | TF_octamer | 1.08e-04 | 3 | 113 | 2 | IPR000972 | |
| Domain | BTB | 1.45e-04 | 131 | 113 | 6 | PF00651 | |
| Domain | BTB | 4.27e-04 | 160 | 113 | 6 | PS50097 | |
| Domain | - | 5.67e-04 | 27 | 113 | 3 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 7.03e-04 | 29 | 113 | 3 | IPR010982 | |
| Domain | BTB | 7.94e-04 | 180 | 113 | 6 | SM00225 | |
| Domain | BTB/POZ_dom | 9.16e-04 | 185 | 113 | 6 | IPR000210 | |
| Domain | Clathrin_H-chain/VPS_repeat | 9.92e-04 | 8 | 113 | 2 | IPR000547 | |
| Domain | SKP1/BTB/POZ | 1.02e-03 | 189 | 113 | 6 | IPR011333 | |
| Domain | EF-hand-dom_pair | 1.82e-03 | 287 | 113 | 7 | IPR011992 | |
| Domain | DHR-1_domain | 1.93e-03 | 11 | 113 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.93e-03 | 11 | 113 | 2 | PS51651 | |
| Domain | DHR_1 | 1.93e-03 | 11 | 113 | 2 | PS51650 | |
| Domain | DHR-2 | 1.93e-03 | 11 | 113 | 2 | PF06920 | |
| Domain | DOCK | 1.93e-03 | 11 | 113 | 2 | IPR026791 | |
| Domain | DOCK_C | 1.93e-03 | 11 | 113 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 1.93e-03 | 11 | 113 | 2 | PF14429 | |
| Domain | DHR-2 | 1.93e-03 | 11 | 113 | 2 | IPR027357 | |
| Domain | BTB-kelch_protein | 2.23e-03 | 43 | 113 | 3 | IPR017096 | |
| Domain | Znf_hrmn_rcpt | 2.71e-03 | 46 | 113 | 3 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.71e-03 | 46 | 113 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.71e-03 | 46 | 113 | 3 | PS00031 | |
| Domain | ZnF_C4 | 2.71e-03 | 46 | 113 | 3 | SM00399 | |
| Domain | zf-C4 | 2.71e-03 | 46 | 113 | 3 | PF00105 | |
| Domain | Nuclear_hrmn_rcpt | 2.71e-03 | 46 | 113 | 3 | IPR001723 | |
| Domain | Calpain_III | 2.71e-03 | 13 | 113 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 2.71e-03 | 13 | 113 | 2 | IPR022682 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 3.06e-03 | 48 | 113 | 3 | IPR000536 | |
| Domain | HOLI | 3.06e-03 | 48 | 113 | 3 | SM00430 | |
| Domain | Hormone_recep | 3.06e-03 | 48 | 113 | 3 | PF00104 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.15e-03 | 14 | 113 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.15e-03 | 14 | 113 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.15e-03 | 14 | 113 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.15e-03 | 14 | 113 | 2 | PF08393 | |
| Domain | Calpain_cysteine_protease | 3.15e-03 | 14 | 113 | 2 | IPR022684 | |
| Domain | MT | 3.15e-03 | 14 | 113 | 2 | PF12777 | |
| Domain | AAA_8 | 3.15e-03 | 14 | 113 | 2 | PF12780 | |
| Domain | DHC_fam | 3.62e-03 | 15 | 113 | 2 | IPR026983 | |
| Domain | Peptidase_C2 | 3.62e-03 | 15 | 113 | 2 | PF00648 | |
| Domain | Dynein_heavy | 3.62e-03 | 15 | 113 | 2 | PF03028 | |
| Domain | CysPc | 3.62e-03 | 15 | 113 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 3.62e-03 | 15 | 113 | 2 | IPR001300 | |
| Domain | Dynein_heavy_dom | 3.62e-03 | 15 | 113 | 2 | IPR004273 | |
| Domain | CALPAIN_CAT | 3.62e-03 | 15 | 113 | 2 | PS50203 | |
| Domain | POU | 4.12e-03 | 16 | 113 | 2 | SM00352 | |
| Domain | POU_dom | 4.12e-03 | 16 | 113 | 2 | IPR000327 | |
| Domain | Pou | 4.12e-03 | 16 | 113 | 2 | PF00157 | |
| Domain | POU_1 | 4.12e-03 | 16 | 113 | 2 | PS00035 | |
| Domain | POU_2 | 4.12e-03 | 16 | 113 | 2 | PS00465 | |
| Domain | POU_3 | 4.12e-03 | 16 | 113 | 2 | PS51179 | |
| Domain | POU | 4.65e-03 | 17 | 113 | 2 | IPR013847 | |
| Domain | Ion_trans_dom | 5.09e-03 | 114 | 113 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.09e-03 | 114 | 113 | 4 | PF00520 | |
| Domain | - | 5.12e-03 | 261 | 113 | 6 | 1.10.238.10 | |
| Domain | Znf_NHR/GATA | 5.23e-03 | 58 | 113 | 3 | IPR013088 | |
| Domain | Kelch | 5.23e-03 | 58 | 113 | 3 | SM00612 | |
| Domain | P-loop_NTPase | KIF23 ABCA12 MYO18A YTHDC2 PAPSS2 DNAH7 ABCC6 DNAH1 NLRP9 SMARCA4 HFM1 GNAO1 | 5.24e-03 | 848 | 113 | 12 | IPR027417 |
| Domain | Gal_Oxase/kelch_b-propeller | 5.48e-03 | 59 | 113 | 3 | IPR011043 | |
| Domain | - | ABCA12 MYO18A YTHDC2 PAPSS2 DNAH7 ABCC6 DNAH1 NLRP9 SMARCA4 HFM1 GNAO1 | 5.53e-03 | 746 | 113 | 11 | 3.40.50.300 |
| Domain | BACK | 5.74e-03 | 60 | 113 | 3 | SM00875 | |
| Domain | BACK | 6.02e-03 | 61 | 113 | 3 | IPR011705 | |
| Domain | BACK | 6.02e-03 | 61 | 113 | 3 | PF07707 | |
| Domain | ARM-like | 6.02e-03 | 270 | 113 | 6 | IPR011989 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 9.26e-07 | 32 | 80 | 5 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.09e-06 | 33 | 80 | 5 | M39875 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.77e-06 | 18 | 80 | 4 | M48098 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.58e-05 | 56 | 80 | 5 | M27616 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.80e-05 | 67 | 80 | 5 | MM15327 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.33e-04 | 87 | 80 | 5 | M27617 | |
| Pubmed | 3.62e-13 | 5 | 115 | 5 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 3.62e-13 | 5 | 115 | 5 | 10996085 | |
| Pubmed | 2.17e-12 | 6 | 115 | 5 | 21838267 | ||
| Pubmed | 2.17e-12 | 6 | 115 | 5 | 29724786 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 2.01e-11 | 8 | 115 | 5 | 30871858 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.13e-10 | 4 | 115 | 4 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.13e-10 | 4 | 115 | 4 | 22671294 | |
| Pubmed | 1.13e-10 | 4 | 115 | 4 | 16077734 | ||
| Pubmed | 1.65e-10 | 11 | 115 | 5 | 32973045 | ||
| Pubmed | 1.65e-10 | 11 | 115 | 5 | 26403076 | ||
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 5.66e-10 | 5 | 115 | 4 | 15620359 | |
| Pubmed | 1.06e-09 | 15 | 115 | 5 | 18227507 | ||
| Pubmed | 1.41e-08 | 9 | 115 | 4 | 9278515 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 2.25e-08 | 26 | 115 | 5 | 34848499 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 19776007 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 33316546 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 9038233 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 28607166 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 28704475 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.52e-08 | 3 | 115 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.52e-08 | 3 | 115 | 3 | 22341088 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 32380082 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23667648 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 10490647 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 28877989 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 19800850 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 38987795 | ||
| Pubmed | Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. | 3.52e-08 | 3 | 115 | 3 | 9584182 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 37105392 | ||
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 3.52e-08 | 3 | 115 | 3 | 29100073 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 36479526 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.52e-08 | 3 | 115 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.52e-08 | 3 | 115 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.52e-08 | 3 | 115 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.52e-08 | 3 | 115 | 3 | 35241678 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 22627368 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 26291161 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 33153471 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 22052881 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 3.52e-08 | 3 | 115 | 3 | 17897391 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 16982420 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.52e-08 | 3 | 115 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.52e-08 | 3 | 115 | 3 | 29458010 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 26582205 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 9153289 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18974023 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.52e-08 | 3 | 115 | 3 | 29651447 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 21146220 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 32011705 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.52e-08 | 3 | 115 | 3 | 28990062 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18579572 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 27217145 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 16990264 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18005988 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23585851 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18628683 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.52e-08 | 3 | 115 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.52e-08 | 3 | 115 | 3 | 25898318 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 31937306 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 21426359 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18282810 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 24083426 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.52e-08 | 3 | 115 | 3 | 25931247 | |
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 3.52e-08 | 3 | 115 | 3 | 21282647 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17560833 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 7.93e-08 | 13 | 115 | 4 | 27050589 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 38686388 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 22677125 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19234217 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 35715604 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.41e-07 | 4 | 115 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.41e-07 | 4 | 115 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.41e-07 | 4 | 115 | 3 | 33727589 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 25578313 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 18826117 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.41e-07 | 4 | 115 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.41e-07 | 4 | 115 | 3 | 18346632 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19670381 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.41e-07 | 4 | 115 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.41e-07 | 4 | 115 | 3 | 34369876 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 30056576 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 33203936 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 20579107 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.41e-07 | 4 | 115 | 3 | 33963043 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 33107565 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.41e-07 | 4 | 115 | 3 | 19362679 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.41e-07 | 4 | 115 | 3 | 20463811 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.41e-07 | 4 | 115 | 3 | 23657851 | |
| Interaction | NLGN4Y interactions | 3.48e-06 | 6 | 114 | 3 | int:NLGN4Y | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.43e-05 | 134 | 71 | 6 | 861 | |
| GeneFamily | Galectins | 2.55e-05 | 15 | 71 | 3 | 629 | |
| GeneFamily | Kelch like|BTB domain containing | 5.97e-04 | 42 | 71 | 3 | 617 | |
| GeneFamily | Nuclear hormone receptors | 9.39e-04 | 49 | 71 | 3 | 71 | |
| GeneFamily | C2 domain containing|Calpains | 1.54e-03 | 15 | 71 | 2 | 975 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 3.65e-03 | 23 | 71 | 2 | 523 | |
| GeneFamily | PHD finger proteins | 5.34e-03 | 90 | 71 | 3 | 88 | |
| Coexpression | GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP | 2.27e-06 | 135 | 115 | 7 | M447 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_16H_BMDC_DN | 2.94e-06 | 200 | 115 | 8 | M3819 | |
| Coexpression | GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 2.78e-05 | 198 | 115 | 7 | M6217 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-07 | 167 | 115 | 7 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.82e-07 | 176 | 115 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.54e-07 | 186 | 115 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 5.75e-07 | 187 | 115 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.72e-07 | 199 | 115 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.88e-06 | 182 | 115 | 6 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.88e-06 | 182 | 115 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-06 | 182 | 115 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 183 | 115 | 6 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 190 | 115 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 191 | 115 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.17e-05 | 195 | 115 | 6 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.31e-05 | 199 | 115 | 6 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | a4c41509ca936e137230a6ae548c90f18a566d12 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 160 | 115 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 160 | 115 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.34e-05 | 162 | 115 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 169 | 115 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.19e-05 | 171 | 115 | 5 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.65e-05 | 173 | 115 | 5 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.65e-05 | 173 | 115 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.89e-05 | 174 | 115 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 175 | 115 | 5 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 175 | 115 | 5 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 9.38e-05 | 176 | 115 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 177 | 115 | 5 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.63e-05 | 177 | 115 | 5 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 177 | 115 | 5 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 177 | 115 | 5 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.63e-05 | 177 | 115 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.89e-05 | 178 | 115 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 179 | 115 | 5 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 179 | 115 | 5 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 180 | 115 | 5 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 180 | 115 | 5 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 180 | 115 | 5 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 181 | 115 | 5 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 182 | 115 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 182 | 115 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 183 | 115 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.16e-04 | 184 | 115 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 184 | 115 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 184 | 115 | 5 | 7aa245b73e10fd73d292e822de6b72920aa12355 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 184 | 115 | 5 | 4f4aeef3b821a003e857fe4a195124d44b2d7479 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 184 | 115 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 184 | 115 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 185 | 115 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.19e-04 | 185 | 115 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 185 | 115 | 5 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 185 | 115 | 5 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 185 | 115 | 5 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 185 | 115 | 5 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 186 | 115 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 186 | 115 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.25e-04 | 187 | 115 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.28e-04 | 188 | 115 | 5 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 188 | 115 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 188 | 115 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.28e-04 | 188 | 115 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.31e-04 | 189 | 115 | 5 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 189 | 115 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.31e-04 | 189 | 115 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.31e-04 | 189 | 115 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 190 | 115 | 5 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-04 | 190 | 115 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 191 | 115 | 5 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 191 | 115 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-04 | 191 | 115 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-04 | 191 | 115 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.38e-04 | 191 | 115 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.38e-04 | 191 | 115 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-04 | 192 | 115 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.41e-04 | 192 | 115 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.41e-04 | 192 | 115 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.41e-04 | 192 | 115 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.41e-04 | 192 | 115 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.41e-04 | 192 | 115 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-04 | 192 | 115 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 193 | 115 | 5 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.44e-04 | 193 | 115 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 193 | 115 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 193 | 115 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-04 | 193 | 115 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-04 | 103 | 115 | 4 | 1b2edf25d6b845e7c07470b2a034654d63917c01 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 194 | 115 | 5 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 194 | 115 | 5 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.48e-04 | 194 | 115 | 5 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 194 | 115 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 194 | 115 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 194 | 115 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.71e-06 | 152 | 110 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.70e-05 | 85 | 110 | 5 | C1510586 | |
| Disease | immune system disease (implicated_via_orthology) | 4.12e-05 | 3 | 110 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 2.05e-04 | 6 | 110 | 2 | C3463992 | |
| Disease | insomnia measurement | 2.61e-04 | 443 | 110 | 8 | EFO_0007876 | |
| Disease | Nephronophthisis, familial juvenile | 2.86e-04 | 7 | 110 | 2 | C1855681 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 2.86e-04 | 7 | 110 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 2.86e-04 | 7 | 110 | 2 | cv:C0403553 | |
| Disease | serum iron measurement | 3.07e-04 | 86 | 110 | 4 | EFO_0006332 | |
| Disease | X-linked infantile spasms | 3.80e-04 | 8 | 110 | 2 | C4552072 | |
| Disease | autistic disorder (is_implicated_in) | 5.21e-04 | 42 | 110 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | thyroid peroxidase antibody measurement, anti-thyroglobulin antibody measurement | 6.38e-04 | 45 | 110 | 3 | EFO_0005666, EFO_0009896 | |
| Disease | Ciliopathies | 7.79e-04 | 110 | 110 | 4 | C4277690 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 8.87e-04 | 12 | 110 | 2 | C0403553 | |
| Disease | response to simvastatin, total cholesterol change measurement, response to fenofibrate | 9.22e-04 | 51 | 110 | 3 | EFO_0007806, GO_1901557, GO_1903491 | |
| Disease | Nephronophthisis | 1.05e-03 | 13 | 110 | 2 | C0687120 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0009935 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.40e-03 | 15 | 110 | 2 | OBA_2045067 | |
| Disease | Sjogren syndrome | 1.48e-03 | 60 | 110 | 3 | EFO_0000699 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.60e-03 | 16 | 110 | 2 | C0393706 | |
| Disease | Antihistamine use measurement | 1.81e-03 | 17 | 110 | 2 | EFO_0009943 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.81e-03 | 17 | 110 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | magnesium measurement | 1.94e-03 | 66 | 110 | 3 | EFO_0004845 | |
| Disease | nephrotic syndrome (is_marker_for) | 2.03e-03 | 18 | 110 | 2 | DOID:1184 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.10e-03 | 144 | 110 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | urinary microalbumin measurement | 2.50e-03 | 20 | 110 | 2 | EFO_0010967 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.68e-03 | 154 | 110 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | juvenile idiopathic arthritis | 2.70e-03 | 74 | 110 | 3 | EFO_0002609 | |
| Disease | Infiltrating duct carcinoma of female breast | 2.76e-03 | 21 | 110 | 2 | C3165106 | |
| Disease | Autistic Disorder | 3.00e-03 | 261 | 110 | 5 | C0004352 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.03e-03 | 22 | 110 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | eosinophilic esophagitis | 3.29e-03 | 163 | 110 | 4 | EFO_0004232 | |
| Disease | frailty measurement | 3.31e-03 | 23 | 110 | 2 | EFO_0009885 | |
| Disease | gamma-linolenic acid measurement | 3.60e-03 | 24 | 110 | 2 | EFO_0007762 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMRDEVFKSNLVCAF | 706 | P40145 | |
| AEYKQMQCDFQLLSE | 301 | Q96M83 | |
| VFNKFCLSNMTLLES | 206 | Q86UK0 | |
| EDFNLIVTNCMKYNA | 656 | Q9ULD4 | |
| SCQDFQQKFIAMFIC | 316 | Q6MZZ7 | |
| KFDGFNINTCREMIS | 571 | A6NHC0 | |
| CSRLQDKMNFDVSNL | 1041 | Q9UPS8 | |
| ACNDTLQQLMEVFKF | 126 | P01008 | |
| DSLEKCNLAMTQNYE | 76 | Q05D60 | |
| LRFLDYEMQNSNECK | 216 | Q8TDF5 | |
| FEKSCQAMFQQINDS | 1126 | Q6P2E9 | |
| ELTMFQNDFEKACQA | 241 | O75665 | |
| MTKEECLQFTANALA | 181 | P28072 | |
| SVEKFNNCTNDMFLF | 56 | O76096 | |
| NNCTNDMFLFKESRI | 61 | O76096 | |
| KCKEMNADAVFAFQL | 396 | O95340 | |
| FLCQKLNLANSETDM | 781 | A4D1F6 | |
| TFTEFGKMQNICNFL | 131 | Q5VVH5 | |
| LVNENRFCNDAMKVA | 76 | O95751 | |
| FQSLDGIMFINKCAT | 51 | Q9NQ38 | |
| LCFLVQSSDFKVMVN | 101 | Q6DKI2 | |
| LCFLVQSSDFKVMVN | 101 | Q3B8N2 | |
| LCFLVQSSDFKVMVN | 101 | O00182 | |
| KECLAVMESYFNENQ | 276 | Q6NT76 | |
| FNELAFFKLMQDLDN | 1681 | Q15154 | |
| NVLDCNDNDPKFMLS | 601 | Q08174 | |
| TDENNFKMFAVFCAL | 396 | Q9Y233 | |
| LMNDIFNKECRQSLS | 626 | P53618 | |
| EMNCKEDQFQLSLLA | 681 | P53618 | |
| FQQACFREQSLAMLS | 521 | Q8WU58 | |
| SNQLEKMAFFQCREE | 16 | Q86YV6 | |
| ISRFEALNLSFKNMC | 241 | P09086 | |
| QKDTDLSKNLFFQCM | 516 | Q7LBC6 | |
| DKFFLKNNMILCQTD | 116 | Q8TAP4 | |
| NLLNYCFQTFLDKTM | 731 | P04150 | |
| LRKCTFDMFNFLASQ | 2516 | Q9UMN6 | |
| MCFETLLQFSFSNKV | 1581 | Q7Z3U7 | |
| TELFPCNFSKNDVML | 561 | Q8N2Q7 | |
| DCLQSNEMVLQFLAF | 636 | O75161 | |
| ISRFEALNLSFKNMC | 326 | P14859 | |
| SFYQEKDMLSNCRQN | 76 | P09630 | |
| MLKSNDCLFSLENLF | 1 | A2PYH4 | |
| DVAMCFIKNQAAFEQ | 5766 | Q5VST9 | |
| FNAKTISLLECFAQM | 96 | Q8NGI1 | |
| LFPCNFSKNDVMLSA | 541 | Q9NZ94 | |
| ELFSCNFSKNDVMLS | 506 | Q8NFZ3 | |
| FENERNMFGKLSQLC | 176 | Q5TID7 | |
| NMFGKLSQLCISNDF | 181 | Q5TID7 | |
| QTVVFNCSDQLDFMA | 1601 | Q9P2D7 | |
| SLVQFMNSLEFCNAV | 281 | Q05DH4 | |
| NCVDLMQAAEVFSQK | 146 | Q53G59 | |
| FSPMASQENCLEKFI | 1041 | Q6AI39 | |
| NAFFQECQKREKDMS | 861 | Q96BY6 | |
| SKDNRMSCTVNLLNF | 1196 | Q92608 | |
| MSCTVNLLNFYKDNN | 1201 | Q92608 | |
| KLESFFNCAAALMTL | 356 | Q8WXX0 | |
| QLQAFMDESTQCFQK | 301 | Q9H410 | |
| TLLDFCDPDQMKFTQ | 661 | Q5U5Z8 | |
| LKTNFFATRNMCNEL | 111 | O75828 | |
| QSKMNCDRVFNVFCL | 391 | P14866 | |
| NNNTCKDFLIEAMKY | 261 | Q9UH77 | |
| FFMNSCNLEVKGTQL | 96 | Q8N4M1 | |
| MCLSNFQTIRKNEDF | 171 | O14682 | |
| MANIQHFLVDQFKCS | 321 | P57679 | |
| ALSMLNDELKCVNFQ | 271 | A6NE01 | |
| NCETDTLINYMAKFA | 841 | P53992 | |
| QENFLLQFKMDACST | 181 | O76038 | |
| FNCNLNHLMSQDDIK | 3391 | Q9NZJ4 | |
| NFCEDTIFEMQLAAQ | 4191 | Q92736 | |
| TDLFPCNFSKNDVML | 516 | Q8NFZ4 | |
| ELFSCNFSKNDVMLS | 506 | Q8N0W4 | |
| YVFKSNDRNSMDIQC | 151 | Q02241 | |
| FSMALCDQEKTFRQQ | 146 | P47712 | |
| NMNIKLTDFGFSCQL | 161 | Q16816 | |
| NEEYACMKAINFLNQ | 386 | Q15406 | |
| FLKTLEECMQIANAA | 46 | O95397 | |
| RDSNCNYEAFMNIIK | 281 | Q9Y5W8 | |
| TKQLFEFMNFLAENV | 361 | Q8IVB4 | |
| KMCLQTLQAADTQEF | 416 | Q8N6T0 | |
| MFLSACLQTLFEQQN | 356 | O95255 | |
| MLQLTCFKDVDISNF | 181 | Q6IFN5 | |
| ESLMLFDSICNNKFF | 246 | P09471 | |
| TLFRNSCFSEDQMAK | 3066 | Q96Q15 | |
| EKDVMLLCQNAQTFN | 1526 | P51532 | |
| DKIMAELQAFQKCSF | 1131 | Q5T5P2 | |
| ELQAFQKCSFMDVNS | 1136 | Q5T5P2 | |
| ENCFKLMFIQSQGQV | 1061 | Q96ST3 | |
| IQFLVMSKCNNEAFT | 971 | Q8NEZ3 | |
| ILSESVMNLFKDCNF | 1076 | Q9UHV7 | |
| QFMEFEKLSQFAAAL | 1821 | P35498 | |
| IAFPSDEDMCQKFLQ | 476 | Q96M20 | |
| IINMNLNKCDSAFDI | 286 | Q8N999 | |
| ELCSMFITNKNFQIL | 621 | Q7RTR0 | |
| MGTFCSVIKFENLQE | 1 | Q9H6R6 | |
| DSMCNEFSQIFQLCQ | 196 | O14980 | |
| FLAENNKLCETVMAQ | 856 | Q7Z3J2 | |
| EIICMIQNTFNFSLK | 346 | Q9BX84 | |
| NAECVMLQNVSKESF | 991 | O75970 | |
| QNFQEEACFILDTMK | 476 | Q12800 | |
| AEAMGKFKQCFLNQS | 56 | O75556 | |
| FLAQKIFNDNSLSME | 476 | P42226 | |
| ANRDAAQALMTFFNK | 506 | Q9P2N2 | |
| NMDQLIEFKAFVSCL | 891 | O95759 | |
| NKMFEDSQDSCRNLV | 86 | P23497 | |
| EFAKRITGFMELCQN | 286 | Q92753 | |
| NFELAFTMAENLANC | 411 | Q2TAL5 | |
| CFTNLMAEIRDNFIK | 261 | Q9NVG8 | |
| AQLNLSNMKISAECF | 61 | Q9Y2K1 | |
| ERAFCEKNFLSQATM | 916 | Q9H6S0 | |
| TGEEIFNCINSFMQK | 316 | Q49AG3 | |
| FGQTFLQKSDLSMCQ | 91 | Q9UC06 | |
| CQMSQAVLDEDLFNF | 351 | Q96MP5 | |
| MDKFAEDLTNRCNVF | 426 | Q2M389 | |
| ELVQCQEKMASFSFL | 2101 | Q9BXT5 | |
| DQCMTALDLFLTNQF | 26 | Q5SRH9 | |
| SLSQRVMCNDLFKVN | 66 | O95411 | |
| RFLDFKIQNMVGSCD | 286 | Q6SJ96 | |
| LFCQKRFDESMQVFA | 356 | Q96JC1 | |
| AASYLQMNDVVNFCK | 101 | Q8NAP8 | |
| SCKFLFGVETNEQLM | 66 | Q96L42 | |
| CQNFAPSFKESEMNV | 421 | Q96BF6 | |
| IQKNLNDNEMLFHSC | 346 | Q5VVJ2 |